DK0900211T3 - Thiadiazolyl(thio)urinstoffer, der er nyttige som matrixmetalloproteaseinhibitorer - Google Patents

Thiadiazolyl(thio)urinstoffer, der er nyttige som matrixmetalloproteaseinhibitorer

Info

Publication number
DK0900211T3
DK0900211T3 DK97917801T DK97917801T DK0900211T3 DK 0900211 T3 DK0900211 T3 DK 0900211T3 DK 97917801 T DK97917801 T DK 97917801T DK 97917801 T DK97917801 T DK 97917801T DK 0900211 T3 DK0900211 T3 DK 0900211T3
Authority
DK
Denmark
Prior art keywords
ulceration
thiadiazolyl
thio
matrix metalloprotease
present
Prior art date
Application number
DK97917801T
Other languages
English (en)
Inventor
E Jon Jacobsen
Mark A Mitchell
Heinrich Joseph Schostarez
Donald E Harper
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0900211T3 publication Critical patent/DK0900211T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Detergent Compositions (AREA)
  • Glass Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97917801T 1996-04-23 1997-04-10 Thiadiazolyl(thio)urinstoffer, der er nyttige som matrixmetalloproteaseinhibitorer DK0900211T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1600396P 1996-04-23 1996-04-23
PCT/US1997/005428 WO1997040031A1 (en) 1996-04-23 1997-04-10 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors

Publications (1)

Publication Number Publication Date
DK0900211T3 true DK0900211T3 (da) 2003-10-27

Family

ID=21774823

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97917801T DK0900211T3 (da) 1996-04-23 1997-04-10 Thiadiazolyl(thio)urinstoffer, der er nyttige som matrixmetalloproteaseinhibitorer

Country Status (9)

Country Link
EP (1) EP0900211B1 (da)
JP (1) JP2000509039A (da)
AT (1) ATE244229T1 (da)
AU (1) AU2603697A (da)
DE (1) DE69723258T2 (da)
DK (1) DK0900211T3 (da)
ES (1) ES2202602T3 (da)
PT (1) PT900211E (da)
WO (1) WO1997040031A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000514787A (ja) * 1996-06-21 2000-11-07 ファルマシア・アンド・アップジョン・カンパニー チアジアゾールアミドｍｍｐ阻害剤
CA2369666A1 (en) * 1999-04-07 2000-10-19 Santen Pharmaceutical Co., Ltd. N-substituted-n'-substituted urea derivatives and the use thereof as tnf-.alpha production inhibitory agents
DE19960640A1 (de) 1999-12-16 2001-06-28 Aventis Pharma Gmbh Neue Stromelysin Inhibitoren
ES2200617B1 (es) * 2001-01-19 2005-05-01 Almirall Prodesfarma, S.A. Derivados de urea como antagonistas de integrinas alfa 4.
US7115607B2 (en) 2001-07-25 2006-10-03 Amgen Inc. Substituted piperazinyl amides and methods of use
JP4825375B2 (ja) * 2001-08-28 2011-11-30 株式会社 資生堂 ジチアゾール化合物及びマトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤
DE102006047155A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninethylester und einem oder mehreren Antioxidantien
DE102006047157A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren hautaufhellenden Wirkstoffen gegen unerwünschte Pigmentierung der Haut, insbesondere postinflammatorische Hyperpigmentierung
DE102006047164A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren Hautbefeuchtungsmitteln
DE102006047160A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit (R)-2-[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-propionsäure-methylester und einem oder mehreren Füllstoffen
DE102006047163A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren Antioxidantien
DE102006047153A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren anti-entzündlichen Wirkstoffen
JP5580544B2 (ja) * 2009-03-25 2014-08-27 国立大学法人群馬大学 がん治療用の遊走阻害剤
EP2511510B1 (en) 2011-04-15 2014-10-08 Caterpillar Motoren GmbH & Co. KG Engine block and internal combustion engine with an engine block
EP2511511B1 (en) 2011-04-15 2016-05-11 Caterpillar Motoren GmbH & Co. KG Charge air guide element and internal combustion engine with a charge air guide element
EP2527610B1 (en) 2011-05-27 2015-03-18 Caterpillar Motoren GmbH & Co. KG SCR catalyst section and turbocharged engine therewith

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220954A (ja) * 1986-03-20 1987-09-29 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US5239078A (en) * 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
UA43358C2 (uk) * 1994-01-20 2001-12-17 Брітіш Біотек Фармасьютікелз Лімітед Інгібітори металопротеіназ, спосіб їх отримання (варіанти), спосіб лікування, спосіб отримання засобу для лікування та фармацевтична композиція
US5677282A (en) * 1995-06-07 1997-10-14 Proscript, Inc. Amino acid amides of 1,3,4-thiadiazoles as matrix metalloproteinase

Also Published As

Publication number Publication date
DE69723258D1 (de) 2003-08-07
ATE244229T1 (de) 2003-07-15
WO1997040031A1 (en) 1997-10-30
ES2202602T3 (es) 2004-04-01
AU2603697A (en) 1997-11-12
EP0900211B1 (en) 2003-07-02
PT900211E (pt) 2003-10-31
EP0900211A1 (en) 1999-03-10
JP2000509039A (ja) 2000-07-18
DE69723258T2 (de) 2004-01-29

Similar Documents

Publication Publication Date Title
MY117762A (en) Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation
DK0900211T3 (da) Thiadiazolyl(thio)urinstoffer, der er nyttige som matrixmetalloproteaseinhibitorer
MX9804793A (es) Acidos arilsulfonamido-hidroxamicos alfa-sustituidos como inhibidores de factor de necrosis tumoral-alfa y de metaloproteinasa de matriz.
HUP0000641A2 (hu) orto-Szulfonamido-aril-hidroxámsav-származékok, mátrix metalloprotenáz, valamint TACE-gátlóként való alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
CA2152792A1 (en) Novel 3,4-Diaryl Thiophenes and Analogs Thereof Having Use As Antiinflammatory Agents
GB8827305D0 (en) Compounds
YU40999A (sh) N-hidroksi-2-(alkil,aril ili heteroaril sulfanil,sulfinil ili sulfonil)-3-supstituisani alkil,aril ili heteroarilamidi, kao inhibitori za matrične metaloproteinaze
DE69510198D1 (de) Succinyl hydroxamsäure-, n-formyl-n-hydroxy-aminocarbonsäure- und succinsäureamid-derivate und ihre verwendung als metalloprotease-inhibitoren
TNSN02013A1 (fr) Derives de benzothiadiazine, nouveaux inhibiteurs de metalloproteinases de matrice, et compositions les contenant
HK1022468A1 (en) Beta-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors.
NO963370L (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
NO995268L (no) Proteaseinhibitorer
WO2002053146A3 (en) Matrix metalloproteinase inhibitors
AU3474797A (en) Thiadiazole amide mmp inhibitors
DK1134215T3 (da) 2-oxo-imidazolidin-4-carboxylsyrehydroxaminforbindelser, som inhiberer matrixmetalloproteinaser
AU6602594A (en) New phosphonic acid compounds, process for preparing them and pharmaceutical compositions containing them
TW363056B (en) Inhibition of matrix metalloproteases by substituted phenethyl compounds
FR2775976B1 (fr) Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase
CA2244903A1 (en) Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
GB0001572D0 (en) Inhibitors